Corporate Strategies

Our unique coverage of over 60 country markets allows users to monitor their competitors' activities in a wide range of developing markets in Latin America, Asia, Eastern Europe and the Middle East/Africa, alongside the more mature markets of Western Europe, North America and Japan.

Our comprehensive daily monitoring of the top 60 pharmaceutical players—including: Big Pharma, leading specialist, biotech and generics manufacturers, and many domestic players in all the markets we cover—provides our users with an unrivalled competitor intelligence tool. We provide constant and ongoing analysis of drug collaborations, new product launches, patent expiries and challenges, M&A activity, and corporate strategy developments.

The Same-day Analysis is complemented by a series of Special Reports that focus on longer-term strategic trends in the industry such as the long-term issues facing the traditional R&D model, the inexorable rise of the generics sector, and the specific challenges facing international pharma players in emerging markets.